Skip to main content
Fig. 2 | BMC Urology

Fig. 2

From: Elevated ADH5 expression suggested better prognosis in kidney renal clear cell carcinoma (KIRC) and related to immunity through single-cell and bulk RNA-sequencing

Fig. 2

The expression and distribution of ADH5 protein in the CPTAC database. (A) Protein expression of ADH5 in natural kidney tissues and KIRC primary tumor tissues; (B) Protein expression of ADH5 in the normal group, mTOR pathway altered group, and other groups; (C) ADH5 protein expression in different stages; (D) ADH5 protein expression in different grades. (E) ADH5 phosphoprotein expression at the S351 locus in normal kidney tissues and KIRC primary tumor tissues; (F) ADH5 phosphoprotein expression at the S351 locus in the normal group, mTOR pathway altered group, and other groups; (G) Protein expression at the ADH5 phosphoprotein at the S351 locus in different stages; (H) Protein expression at the ADH5 phosphoprotein at the S351 locus in different grades. *P < 0.05, **P < 0.01, ***P < 0.001

Back to article page

BMC Urology

ISSN: 1471-2490

Contact us